Cypherpunk Technologies Inc. (CYPH )

Currency in USD Disclaimer
$3.12 +$0.37 (13.41%)
Open 11/17/2025
$2.8
$3.42
$0.22
$3.58

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol CYPH
  • Company Cypherpunk Technologies Inc.
  • Price $3.12
  • Changes Percentage 13.41
  • Change 0.3687
  • Day Low $2.8
  • Day High $3.42
  • Year High $3.58
  • Year Low $0.22
  • Market Cap $179,178,440
  • Price Avg 50 EMA (D) $0.56
  • Price Avg 200 EMA (D) $0.42
  • Exchange NASDAQ
  • Volume 66,527,622
  • Average Volume 20,127,893
  • Open $3.04
  • Previous Close $2.75
  • EPS -1.58
  • PE -2.00
  • Earnings Announcement 2026-03-25 04:00:00
  • Shares Outstanding $56,651,840

Company brief: CYPHERPUNK TECHNOLOGIES INC. (CYPH )

Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.

CYPH Corporation News

Income Statement